Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent discussions he has had with his counterparts in the Welsh Government on making Evusheld available to immunocompromised people.

On 17 March 2022, Evusheld was granted conditional marketing approval by the Medicines and Healthcare products Regulatory Agency (MHRA). However, the MHRA highlighted uncertainty over the appropriate dose needed for protection against the Omicron variant. Understanding its efficacy is necessary prior to any procurement or deployment decisions. Officials in the Antivirals and Therapeutics Taskforce regularly engage with the Welsh Government.